The present invention relates to the use of an active substance that promotes the inhibition of the formation of AGEs, for preparing a composition to prevent and/or combat the reduction in elastic and plastic properties of tissues, and in particular of the skin, for inhibiting the formation of AGEs, or for preventing and/or combating glycation of proteins in the skin.
The invention also relates to a method of screening such active substances.
NOVEL GLYCOSYLTRANSFERASE, NOVEL GLYCOSYLTRANSFERASE GENE, AND NOVEL SUGAR DONOR COMPOUND
申请人:Ozeki Yoshihiro
公开号:US20120135469A1
公开(公告)日:2012-05-31
An object of the present invention is to provide a sugar donating reagent comprising a sugar donor compound other than a sugar nucleotide and an enzyme capable of catalyzing a glycosyl transfer reaction using a sugar donor compound other than a sugar nucleotide. The present invention provides the following: a sugar donating reagent containing a compound of formula (A):
wherein R
1
is independently selected from hydrogen, or C
1-6
alkyl, C
2-6
alkenyl, and C
2-6
alkynyl in which each of the groups is unsubstituted or substituted with one or more groups selected from OH, F, Cl, Br, I, CN, NO
2
, and SO
2
, n is 0, 1, 2, 3, 4 or 5, m is 0 or 1, and X represents a monosaccharide bound via a β bond on its anomeric carbon; a glycosyltransferase capable of catalyzing a glycosyl transfer reaction using the sugar donor; and a glycosyltransferase gene comprising DNA encoding the glycosyltransferase.
Pharmaceutical composition containing substance inhibiting HSP47 production
申请人:Kureha Chemical Industry Co., Ltd.
公开号:EP0742012A2
公开(公告)日:1996-11-13
A pharmaceutical composition comprising a substance inhibiting HSP47 production, selected from the group consisting of a malt extract, a flavonoid compound, a protein-bound-polysaccharide obtained from a fungus belonging to Coriolus versicolor, a paeoniflorin derivative, a tocopherol derivative, and a ferulic acid derivative, and a pharmaceutically acceptable carrier is disclosed. The substance inhibiting HSP47 production can efficiently improve physiological conditions of a patient suffering from diseases exhibiting pathosis of overproduction of the extracellular matrix, and efficiently treat such diseases. Further, the substance is useful for preventing or treating various diseases accompanied with abnormal growth of the vascularization.
SUCRALOSE-CONTAINING COMPOSITION AND EATABLE PRODUCT COMPRISING THE SAME
申请人:SAN-EI GEN F.F.I., INC.
公开号:EP1177728A1
公开(公告)日:2002-02-06
A composition which is obtained by causing a specific compound to be present together with sucralose. The composition provides a sucralose in a stable form, more particularly, a sucralose which is still stable and thus is significantly suppressed wiht respect to the decrease in sweetness and discoloration (browning, blackening), even when it is subjected to a heating treatment under a condition wherein temperature is high and especially water content is low and/or pH is low. The stabilized sucralose-containing composition can be used as a sweetener by itself and as a compound with a food or a drug.
An object of the represent invention is to provide a method of detecting viable cells that can detect and quantify viable cells in a sample quickly, readily, and accurately. The reagents used in the method are safe, stable in storage, and inexpensive.
The method comprises steps (1), (2) and (3).
In the step (1), the cells are fluorescently stained by adding a fluorescent dye into the sample or making the sample in contact with the fluorescent dye.
In the step (2), a quenching dye is added to the sample stained with the fluorescent dye, or the sample is made in contact with the quenching dye, under a condition of a pH value that is different from the pH value in the viable cells. The quenching dye used in this step, (a) is permeable through a membrane of a viable cell, (b) hardly absorbs fluorescence of the fluorescent dye under a condition of the pH value in the viable cells, but (c) absorbs the fluorescence of the fluorescent dye under a condition different from the pH value of the fluorescent dye.
In the step (3), the sample stained with the fluorescent dye and the quenching dye is illuminated by an excitation light for the fluorescent dye under a condition of a pH value different from the pH value in the viable cells and the fluorescence emitted from the sample is collected and detected.